Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pfizer's share price for the quarter that ended in Mar. 2026 was ₹4719.75. Pfizer's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 46 Mil. Therefore, Pfizer's market cap for the quarter that ended in Mar. 2026 was ₹215,919 Mil.
Pfizer's quarterly market cap
declined
from Sep. 2025 (₹230,124 Mil) to Dec. 2025 (₹227,939 Mil) and
declined
from Dec. 2025 (₹227,939 Mil) to Mar. 2026 (₹215,919 Mil).
Pfizer's annual market cap
declined
from Mar. 2024 (₹191,842 Mil) to Mar. 2025 (₹183,173 Mil) but then
increased
from Mar. 2025 (₹183,173 Mil) to Mar. 2026 (₹215,919 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pfizer's Enterprise Value for Today is ₹186,269 Mil.
Pfizer (BOM:500680) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pfizer Market Cap Related Terms
Pfizer Market Cap Historical Data
* Premium members only.
The historical data trend for Pfizer's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:500680 vs LLY, JNJ, ABBV: Market Cap Comparison
For the Drug Manufacturers - General subindustry, Pfizer's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pfizer Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pfizer's Market Cap distribution charts can be found below:
* The bar in red indicates where Pfizer's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pfizer's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pfizer (BOM:500680) has a Market Cap of ₹216,451 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pfizer and its competitors. According to the industry distribution chart, Pfizer ranks #144 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 14.1%.
Is Pfizer's Market Cap too high?
Pfizer's current Market Cap is ₹216,451 Mil. Based on the distribution chart, Pfizer ranks #144 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pfizer has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Pfizer ranks #144 out of 1024 companies for Market Cap. This places Pfizer in the top 14% of its industry — outperforming the majority of peers. The industry median Market Cap is 213.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.52, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pfizer and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pfizer's current Market Cap is ₹216,451 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (BOM:500680) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,840.80, compared to a current price of ₹4,728.55 — trading 2.3% below its estimated fair value. The current Market Cap is ₹216,451 Mil. Pfizer's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pfizer (BOM:500680), the current Market Cap is ₹216,451 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pfizer (BOM:500680) Overvalued in 2026?
Based on GuruFocus' analysis, Pfizer stock appears to be undervalued.
The current stock price of ₹4,728.55 is trading 2.3% below its estimated GF Value™ of ₹4,840.80.
GuruFocus considers Pfizer to be Fairly Valued.
Key valuation signals for BOM:500680:
Market Cap: ₹216,451 Mil
GF Value™: ₹4,840.80 vs. price of ₹4,728.55 (2.3% below fair value)
No single metric tells the full story. See the BOM:500680 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has only one segment which is Pharmaceuticals and it operates in domestic market.
77GF Score
Get the complete analysis for BOM:500680
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500680 has been successfully added to your 
